The availability of 750mcg teriparatide injection in Australia has seen modest distribution . Currently, it’s mainly prescribed for patients with severe osteoporosis where other therapies have failed . Obtaining this more potent formulation presents as challenging due to healthcare approval requirements and limited clinic stock . Despite certain